| Literature DB >> 3282177 |
Abstract
Direct payment by patients for treatment with drugs still in development is the subject of controversy. The matter goes deeper than it might first appear.Entities:
Keywords: Biomedical and Behavioral Research; Professional Patient Relationship
Mesh：
Year: 1988 PMID： 3282177 DOI： 10.1038/332795a0
Source DB: PubMed Journal: Nature ISSN： 0028-0836 Impact factor: 49.962